Company news

Cannara Biotech, Inc. news in 2025

Cannara Biotech, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings

November 24, 2025

Cannara Biotech Inc. to Announce Fiscal Q4 2025 and Fiscal Year 2025 Financial Results on November 24, 2025 and Provides Board Update

November 17, 2025

Cannara Announces DTC Eligibility to Facilitate U.S. Investor Access and Strengthens Balance Sheet through completion of Debt-to-Equity Conversion

October 7, 2025

Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance

October 2, 2025

Cannara Announces Grant of Options and RSUs

September 1, 2025

Cannara Announces Amendment and Upsize of BMO Credit Facility to Support Facility Expansion at Valleyfield

August 21, 2025

Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale

August 14, 2025

Cannara Biotech Delivers Highest Revenue and Profitability Since Inception in Fiscal Q3 2025

July 28, 2025

Cannara Secures 5 Key Listings in Québec's New Vape Cartridge Category Including to be Released Live Rosin Vapes

July 24, 2025

Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

July 21, 2025

Cannara Biotech to Host Investor Webcast on June 25th, 2025

June 19, 2025

Cannara Reduces Cost of Debt with Lower Interest Rate and Partial Debenture Repayment; Wins 2025 Brand of the Year

June 18, 2025

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

April 28, 2025

Cannara Biotech Inc. to Announce Fiscal Q2 2025 Financial Results on April 28, 2025

April 16, 2025

Calls in 2025

Decks in 2025